| UniProt ID | NF2L1_HUMAN | |
|---|---|---|
| UniProt AC | Q14494 | |
| Protein Name | Endoplasmic reticulum membrane sensor NFE2L1 {ECO:0000305} | |
| Gene Name | NFE2L1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 772 | |
| Subcellular Localization |
Endoplasmic reticulum membrane sensor NFE2L1: Endoplasmic reticulum membrane Single-pass type II membrane protein . Endoplasmic reticulum membrane Single-pass type III membrane protein . In normal conditions, probably has a single-pass type II me |
|
| Protein Description | Endoplasmic reticulum membrane sensor NFE2L1: Endoplasmic reticulum membrane sensor that translocates into the nucleus in response to various stresses to act as a transcription factor. [PubMed: 20932482] | |
| Protein Sequence | MLSLKKYLTEGLLQFTILLSLIGVRVDVDTYLTSQLPPLREIILGPSSAYTQTQFHNLRNTLDGYGIHPKSIDLDNYFTARRLLSQVRALDRFQVPTTEVNAWLVHRDPEGSVSGSQPNSGLALESSSGLQDVTGPDNGVRESETEQGFGEDLEDLGAVAPPVSGDLTKEDIDLIDILWRQDIDLGAGREVFDYSHRQKEQDVEKELRDGGEQDTWAGEGAEALARNLLVDGETGESFPAQVPSGEDQTALSLEECLRLLEATCPFGENAEFPADISSITEAVPSESEPPALQNNLLSPLLTGTESPFDLEQQWQDLMSIMEMQAMEVNTSASEILYSAPPGDPLSTNYSLAPNTPINQNVSLHQASLGGCSQDFLLFSPEVESLPVASSSTLLPLAPSNSTSLNSTFGSTNLTGLFFPPQLNGTANDTAGPELPDPLGGLLDEAMLDEISLMDLAIEEGFNPVQASQLEEEFDSDSGLSLDSSHSPSSLSSSEGSSSSSSSSSSSSSSASSSASSSFSEEGAVGYSSDSETLDLEEAEGAVGYQPEYSKFCRMSYQDPAQLSCLPYLEHVGHNHTYNMAPSALDSADLPPPSALKKGSKEKQADFLDKQMSRDEHRARAMKIPFTNDKIINLPVEEFNELLSKYQLSEAQLSLIRDIRRRGKNKMAAQNCRKRKLDTILNLERDVEDLQRDKARLLREKVEFLRSLRQMKQKVQSLYQEVFGRLRDENGRPYSPSQYALQYAGDGSVLLIPRTMADQQARRQERKPKDRRK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 3 | Phosphorylation | -----MLSLKKYLTE -----CCCHHHHHHH | 36.52 | - | |
| 61 | Phosphorylation | QFHNLRNTLDGYGIH HHHHHHHCCCCCCCC | 21.57 | 29083192 | |
| 65 | Phosphorylation | LRNTLDGYGIHPKSI HHHCCCCCCCCCCCC | 16.75 | 27174698 | |
| 70 (in isoform 2) | Ubiquitination | - | 45.97 | 21890473 | |
| 70 (in isoform 1) | Ubiquitination | - | 45.97 | 21890473 | |
| 70 | Ubiquitination | DGYGIHPKSIDLDNY CCCCCCCCCCCCCCH | 45.97 | 21890473 | |
| 71 | Phosphorylation | GYGIHPKSIDLDNYF CCCCCCCCCCCCCHH | 26.28 | 27174698 | |
| 77 | Phosphorylation | KSIDLDNYFTARRLL CCCCCCCHHHHHHHH | 11.28 | 27174698 | |
| 79 | Phosphorylation | IDLDNYFTARRLLSQ CCCCCHHHHHHHHHH | 14.64 | 27174698 | |
| 98 | O-linked_Glycosylation | DRFQVPTTEVNAWLV HCCCCCCCEEEEEEE | 31.69 | OGP | |
| 112 | Phosphorylation | VHRDPEGSVSGSQPN EEECCCCCCCCCCCC | 16.08 | 24275569 | |
| 114 | Phosphorylation | RDPEGSVSGSQPNSG ECCCCCCCCCCCCCC | 34.13 | 24275569 | |
| 116 | Phosphorylation | PEGSVSGSQPNSGLA CCCCCCCCCCCCCEE | 34.65 | 24275569 | |
| 120 | Phosphorylation | VSGSQPNSGLALESS CCCCCCCCCEEEECC | 41.70 | 24275569 | |
| 126 | Phosphorylation | NSGLALESSSGLQDV CCCEEEECCCCCCCC | 30.56 | 24275569 | |
| 194 | Phosphorylation | AGREVFDYSHRQKEQ CCCCCCCCCHHHHHH | 8.56 | 23403867 | |
| 195 | Phosphorylation | GREVFDYSHRQKEQD CCCCCCCCHHHHHHH | 17.65 | 23403867 | |
| 199 | Ubiquitination | FDYSHRQKEQDVEKE CCCCHHHHHHHHHHH | 58.25 | - | |
| 205 | Ubiquitination | QKEQDVEKELRDGGE HHHHHHHHHHHHCCC | 62.99 | - | |
| 285 | Phosphorylation | SITEAVPSESEPPAL HHHHCCCCCCCCCHH | 47.35 | 24275569 | |
| 348 | N-linked_Glycosylation | PGDPLSTNYSLAPNT CCCCCCCCCCCCCCC | 22.48 | - | |
| 360 | N-linked_Glycosylation | PNTPINQNVSLHQAS CCCCCCCCCEECCCC | 22.36 | - | |
| 379 | Phosphorylation | SQDFLLFSPEVESLP CCCEECCCCCHHCCC | 21.81 | - | |
| 412 | N-linked_Glycosylation | NSTFGSTNLTGLFFP CCCCCCCCCCEEECC | 36.98 | - | |
| 423 | N-linked_Glycosylation | LFFPPQLNGTANDTA EECCCCCCCCCCCCC | 40.29 | - | |
| 498 | Phosphorylation | SSSEGSSSSSSSSSS CCCCCCCCCCCCCCC | 35.62 | - | |
| 499 | Phosphorylation | SSEGSSSSSSSSSSS CCCCCCCCCCCCCCC | 35.87 | - | |
| 500 | Phosphorylation | SEGSSSSSSSSSSSS CCCCCCCCCCCCCCC | 35.87 | - | |
| 501 | Phosphorylation | EGSSSSSSSSSSSSS CCCCCCCCCCCCCCC | 35.87 | - | |
| 502 | Phosphorylation | GSSSSSSSSSSSSSS CCCCCCCCCCCCCCC | 35.87 | - | |
| 507 | Phosphorylation | SSSSSSSSSSASSSA CCCCCCCCCCCCCCC | 30.20 | - | |
| 508 | Phosphorylation | SSSSSSSSSASSSAS CCCCCCCCCCCCCCC | 31.69 | - | |
| 509 | Phosphorylation | SSSSSSSSASSSASS CCCCCCCCCCCCCCC | 33.83 | - | |
| 528 | Phosphorylation | EGAVGYSSDSETLDL CCCCCCCCCCCEECH | 36.35 | - | |
| 599 (in isoform 2) | Ubiquitination | - | 46.66 | 21890473 | |
| 599 | Phosphorylation | PSALKKGSKEKQADF HHHHCCCCHHHHHHH | 46.66 | 24448410 | |
| 600 | Acetylation | SALKKGSKEKQADFL HHHCCCCHHHHHHHH | 77.06 | 26051181 | |
| 602 | Acetylation | LKKGSKEKQADFLDK HCCCCHHHHHHHHHH | 55.30 | 25953088 | |
| 609 | Ubiquitination | KQADFLDKQMSRDEH HHHHHHHHHCCHHHH | 50.47 | - | |
| 622 | Ubiquitination | EHRARAMKIPFTNDK HHHHHHHCCCCCCCC | 46.36 | - | |
| 629 (in isoform 1) | Ubiquitination | - | 47.78 | 21890473 | |
| 629 | Ubiquitination | KIPFTNDKIINLPVE CCCCCCCCEECCCHH | 47.78 | 21906983 | |
| 643 | Phosphorylation | EEFNELLSKYQLSEA HHHHHHHHHHCCCHH | 41.77 | - | |
| 645 | Phosphorylation | FNELLSKYQLSEAQL HHHHHHHHCCCHHHH | 16.00 | 17693683 | |
| 648 | Phosphorylation | LLSKYQLSEAQLSLI HHHHHCCCHHHHHHH | 18.50 | 29978859 | |
| 653 | Phosphorylation | QLSEAQLSLIRDIRR CCCHHHHHHHHHHHH | 15.07 | 29978859 | |
| 675 | Ubiquitination | AQNCRKRKLDTILNL HHHHHHCHHHHHHCC | 54.47 | - | |
| 678 | Phosphorylation | CRKRKLDTILNLERD HHHCHHHHHHCCHHC | 37.49 | 29083192 | |
| 683 (in isoform 2) | Ubiquitination | - | 45.84 | 21890473 | |
| 693 | Ubiquitination | VEDLQRDKARLLREK HHHHHHHHHHHHHHH | 37.28 | - | |
| 700 | Ubiquitination | KARLLREKVEFLRSL HHHHHHHHHHHHHHH | 40.40 | - | |
| 713 | Ubiquitination | SLRQMKQKVQSLYQE HHHHHHHHHHHHHHH | 36.40 | 2190698 | |
| 713 (in isoform 1) | Ubiquitination | - | 36.40 | 21890473 | |
| 733 | Phosphorylation | RDENGRPYSPSQYAL CCCCCCCCCHHHHHE | 31.67 | 30108239 | |
| 734 | Phosphorylation | DENGRPYSPSQYALQ CCCCCCCCHHHHHEE | 22.28 | 30108239 | |
| 736 | Phosphorylation | NGRPYSPSQYALQYA CCCCCCHHHHHEEEC | 29.86 | 24719451 | |
| 738 | Phosphorylation | RPYSPSQYALQYAGD CCCCHHHHHEEECCC | 17.39 | 30108239 | |
| 742 | Phosphorylation | PSQYALQYAGDGSVL HHHHHEEECCCCCEE | 17.25 | 30108239 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 379 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
| 528 | S | Phosphorylation | Kinase | CK2 | - | Uniprot |
| 599 | S | Phosphorylation | Kinase | PRKACA | P27791 | GPS |
| 599 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
| 599 | S | Phosphorylation | Kinase | PKA | - | Uniprot |
| 599 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
| - | K | Ubiquitination | E3 ubiquitin ligase | FBXW7 | Q969H0 | PMID:24658274 |
| - | K | Ubiquitination | E3 ubiquitin ligase | BTRC | Q9Y297 | PMID:24658274 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NF2L1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| FBXW7_HUMAN | FBXW7 | physical | 21953459 | |
| KEAP1_HUMAN | KEAP1 | physical | 16687406 | |
| FBXW7_HUMAN | FBXW7 | physical | 23623971 | |
| BACH2_HUMAN | BACH2 | physical | 23661758 | |
| NF2L1_HUMAN | NFE2L1 | physical | 23661758 | |
| MAFG_HUMAN | MAFG | physical | 23661758 | |
| MAFF_HUMAN | MAFF | physical | 23661758 | |
| RUSC2_HUMAN | RUSC2 | physical | 26496610 | |
| WDFY3_HUMAN | WDFY3 | physical | 26496610 | |
| CH033_HUMAN | C8orf33 | physical | 26496610 | |
| BRD9_HUMAN | BRD9 | physical | 26496610 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteome profiling of Wnt3a-mediated signalingnetwork: indicating the involvement of ribonucleoside-diphosphatereductase M2 subunit phosphorylation at residue serine 20 in canonicalWnt signal transduction."; Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S.,Li S.-J., Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R.; Mol. Cell. Proteomics 6:1952-1967(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-645, AND MASSSPECTROMETRY. | |